Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole

References

• FountoulakisKNVietaETreatment of bipolar disorder: a systematic review of available data and clinical perspectivesInt J Neuropsychopharmacol200811999102918752718
   PubMed Web of Science ®Google Scholar
• GernerRHPostRMBunneyWEJrA dopaminergic mechanism in maniaAm J Psychiatry197613311771180970489
   PubMed Web of Science ®Google Scholar
• DaviesMAShefflerDJRothBLAripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacologyCNS Drug Rev20041031733615592581
   PubMedGoogle Scholar
• DeLeonAPatelNCCrismonMLAripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerabilityClin Ther20042664966615220010
   PubMed Web of Science ®Google Scholar
• KinghornWAMcEvoyJPAripiprazole: pharmacology, efficacy, safety and tolerabilityExpert Rev Neurother2005529730715938662
   PubMedGoogle Scholar
• KeckPEJrMcElroySLAripiprazole: a partial dopamine D2 receptor agonist antipsychoticExpert Opin Investig Drugs200312655662
   PubMed Web of Science ®Google Scholar
• TadoriYForbesRAMcQuadeRDKikuchiTCharacterization of aripiprazole partial agonist activity at human dopamine D(3) receptorsEur J Pharmacol2008597273318831971
   PubMed Web of Science ®Google Scholar
• GrunderGCarlssonAWongDFMechanism of new antipsychotic medications: occupancy is not just antagonismArch Gen Psychiatry20036097497714557141
   PubMed Web of Science ®Google Scholar
• NatesanSRecklessGENobregaJNFletcherPJKapurSDissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal modelsNeuropsychopharmacology2006311854186316319908
   PubMed Web of Science ®Google Scholar
• HiroseTUwahodoYYamadaSMechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profileJ Psychopharmacol20041837538315358981
   PubMed Web of Science ®Google Scholar
• CitromeLJosiassenRBarkNSalazarDEMallikaarjunSPharmacokinetics of aripiprazole and concomitant lithium and valproateJ Clin Pharmacol200545899315601809
   PubMed Web of Science ®Google Scholar
• Garcia-AmadorMPacchiarottiIValentiMSanchezRFGoikoleaJMVietaERole of aripiprazole in treating mood disordersExpert Rev Neurother200661777178317181424
   PubMedGoogle Scholar
• KeckPEJrMarcusRTourkodimitrisSA placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar maniaAm J Psychiatry20031601651165812944341
   PubMed Web of Science ®Google Scholar
• KeckPEJrCalabreseJRMcIntyreRSAripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placeboJ Clin Psychiatry2007681480149117960961
   PubMed Web of Science ®Google Scholar
• SachsGSanchezRMarcusRAripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled studyJ Psychopharmacol20062053654616401666
   PubMed Web of Science ®Google Scholar
• SachsGSGaulinBDGutierrez-EsteinouRAntimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baselineJ Clin Psychiatry2007681377138317915976
   PubMed Web of Science ®Google Scholar
• FryeMAEudiconeJPikalovAMcQuadeRDMarcusRNCarlsonBXAripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trialsJ Clin Psychopharmacol20082824324518344741
   PubMed Web of Science ®Google Scholar
• SuppesTEudiconeJMcQuadeRPikalovA3rdCarlsonBEfficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorderJ Affect Disord200810714515417904226
   PubMed Web of Science ®Google Scholar
• VietaEBourinMSanchezREffectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trialBr J Psychiatry200518723524216135860
   PubMed Web of Science ®Google Scholar
• KeckPEOrsulakPJCutlerAJAripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled studyJ Affect Disord2009112364918835043
   PubMed Web of Science ®Google Scholar
• VietaET’JoenCMcQuadeRDEfficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled studyAm J Psychiatry20081651316132518381903
   PubMed Web of Science ®Google Scholar
• KeckPEJrCalabreseJRMcQuadeRDA randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorderJ Clin Psychiatry20066762663716669728
   PubMed Web of Science ®Google Scholar
• ZimbroffDLMarcusRNManosGManagement of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazoleJ Clin Psychopharmacol20072717117617414241
   PubMed Web of Science ®Google Scholar
• MuzinaDJMomahCEudiconeJMAripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled studyInt J Clin Pract20086267968718373615
   PubMed Web of Science ®Google Scholar
• MuzinaDJCalabreseJRMaintenance therapies in bipolar disorder: focus on randomized controlled trialsAust N Z J Psychiatry20053965266116050919
   PubMed Web of Science ®Google Scholar
• GhaemiSNHsuDJRosenquistKJPardoTBGoodwinFKExtrapyramidal side effects with atypical neuroleptics in bipolar disorderProg Neuropsychopharmacol Biol Psychiatry20063020921316412546
   PubMed Web of Science ®Google Scholar
• GaoKKempDEGanocySJGajwaniPXiaGCalabreseJRAntipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic reviewJ Clin Psychopharmacol20082820320918344731
   PubMed Web of Science ®Google Scholar
• American Diabetes Association (ADA)Consensus development conference on antipsychotic drugs and obesity and diabetesDiabetes Care20042759660114747245
   PubMed Web of Science ®Google Scholar
• LimHKPaeCULeeCLeeCUTardive dystonic symptoms associated with aripiprazole treatmentProg Neuropsychopharmacol Biol Psychiatry20083258959018053627
   PubMed Web of Science ®Google Scholar
• MaytalGOstacherMSternTAAripiprazole-related tardive dyskinesiaCNS Spectr20061143543916816781
   PubMed Web of Science ®Google Scholar
• ChakrabortyNJohnstonTAripiprazole and neuroleptic malignant syndromeInt Clin Psychopharmacol20041935135315486522
   PubMed Web of Science ®Google Scholar
• ShimJCYouYSKellyDLAripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case reportJ Clin Psychopharmacol20082835335418480699
   PubMed Web of Science ®Google Scholar
• SheldrickAJGrunderGAripiprazole reduces serum prolactin in a woman with prolactinoma and acute psychosisPharmacopsychiatry20084116018651348
   PubMed Web of Science ®Google Scholar
• MalikARRavasiaSAripiprazole-induced seizureCan J Psychiatry20055018615830832
   PubMed Web of Science ®Google Scholar
• TsaiJFAripiprazole-associated seizureJ Clin Psychiatry20066799599616848662
   PubMed Web of Science ®Google Scholar
• GhaemiSNStollALPopeHGJrLack of insight in bipolar disorder. The acute manic episodeJ Nerv Ment Dis19951834644677623019
   PubMed Web of Science ®Google Scholar
• VargaMMagnussonAFlekkoyKRonnebergUOpjordsmoenSInsight, symptoms and neurocognition in bipolar I patientsJ Affect Disord2006911916442637
   PubMed Web of Science ®Google Scholar
• GhaemiSNBoimanEGoodwinFKInsight and outcome in bipolar, unipolar, and anxiety disordersCompr Psychiatry20004116717110834624
   PubMed Web of Science ®Google Scholar
• YenCFChenCSYehMLYangSJKeJHYenJYChanges of insight in manic episodes and influencing factorsCompr Psychiatry20034440440814505301
   PubMed Web of Science ®Google Scholar
• YenCFChenCSYenJYKoCHThe predictive effect of insight on adverse clinical outcomes in bipolar I disorder: a two-year prospective studyJ Affect Disord2008a10812112717997489
   PubMed Web of Science ®Google Scholar
• YenCFChengCPHuangCFYenJYKoCHChenCSQuality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remissionBipolar Disord2008b1061762418657246
   PubMed Web of Science ®Google Scholar
• YenCFChengCPKoCHYenJYHuangCFChenCSSuicidality and its association with insight and neurocognition in taiwanese patients with bipolar I disorder in remissionJ Nerv Ment Dis2008c19646246718552623
   PubMed Web of Science ®Google Scholar
• SajatovicMJenkinsJHIs antipsychotic medication stigmatizing for people with mental illnessInt Rev Psychiatry20071910711217464788
   PubMed Web of Science ®Google Scholar
• CopelandLAZeberJESalloumIMPincusHAFineMJKilbourneAMTreatment adherence and illness insight in veterans with bipolar disorderJ Nerv Ment Dis2008196162118195637
   PubMed Web of Science ®Google Scholar
• FagioliniAPractical guidance for prescribing with aripiprazole in bipolar disorderCurr Med Res Opin2008242691270218702850
   PubMed Web of Science ®Google Scholar